Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

Mark Schenerman

Mark Schenerman is the vice president of analytical biochemistry at MedImmune

Articles by Mark Schenerman